Press "Enter" to skip to content

New patent for Hikma Intl drug MITIGARE


Annual Drug Patent Expirations for MITIGARE
Annual Drug Patent Expirations for MITIGARE

Mitigare is a drug marketed by Hikma Intl Pharms
and is included in one NDA. It is available from two suppliers. There are four patents protecting this drug and one Paragraph IV challenge.

The generic ingredient in MITIGARE is colchicine. Two suppliers are listed for this compound. Additional details are available on the colchicine profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
or visit

Do NOT follow this link or you will be banned from the site!